Medicare Will Start Covering Weight-Loss Drugs On July 1 For The First Time. Here’s What You Need To Know

Millions of Medicare enrollees will gain their first-ever coverage for weight loss medications through the temporary Medicare GLP-1 Bridge pilot program, set to launch on July 1. This initiative, a significant development in healthcare access, will allow beneficiaries to obtain drugs like Wegovy and Zepbound at a substantially reduced cost, addressing a longstanding legal prohibition against Medicare covering such treatments. The program aims to make obesity treatment more equitable and accessible, reflecting ongoing advocacy efforts to recognize obesity as a treatable disease.